Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression

作者: Katharina Domschke , Udo Dannlowski , Christa Hohoff , Patricia Ohrmann , Jochen Bauer

DOI: 10.1016/J.EURONEURO.2009.09.006

关键词:

摘要: Neuropeptide Y (NPY) has been found to play a role in the pathomechanism of both anxiety and depression. Thus, NPY is promising candidate investigation clinical phenotype "anxious depression". Five gene variants were investigated for an influence on antidepressant treatment response sample 256 patients with Additionally, impact amygdala activation during facial emotion processing was analyzed subsample 35 depressed patients. Particularly anxious depression, less active rs16147 -399C allele conferred slow after 2weeks failure achieve remission four weeks treatment. The C further associated stronger bilateral threatening faces allele-dose fashion. present results point towards possible functional variation potentially conveyed by altered emotional processing.

参考文章(67)
Matthew Brett, Jean-Luc Anton, Romain Valabregue, Jean-Baptiste Poline, Region of interest analysis using an SPM toolbox NeuroImage. ,vol. 16, pp. 497- ,(2002)
Carolina Cristi, R. Michael Bagby, Andrew G. Ryder, Psychosocial and clinical predictors of response to pharmacotherapy for depression. Journal of Psychiatry & Neuroscience. ,vol. 27, pp. 250- 257 ,(2002)
Udo Dannlowski, Bernhard Theodor Baune, Harald Kugel, Walter Heindel, Volker Arolt, Jochen Bauer, Thomas Suslow, Patricia Ohrmann, Anette Kersting, Amygdala reactivity to masked negative faces is associated with automatic judgmental bias in major depression: a 3 T fMRI study Journal of Psychiatry & Neuroscience. ,vol. 32, pp. 423- 429 ,(2007)
P. Ekman, Pictures of Facial Affect Consulting Psychologists Press. ,(1976)
A Serretti, M Kato, J L Kennedy, Pharmacogenetic studies in depression: a proposal for methodologic guidelines. Pharmacogenomics Journal. ,vol. 8, pp. 90- 100 ,(2008) , 10.1038/SJ.TPJ.6500477
C. Lindberg, P. Koefoed, E. S. Hansen, T. G. Bolwig, J. F. Rehfeld, E. Mellerup, O. S. Jorgensen, L. V. Kessing, T. Werge, S. Haugbol, A. G. Wang, D. P. D. Woldbye, No association between the −399 C>T polymorphism of the neuropeptide Y gene and schizophrenia, unipolar depression or panic disorder in a Danish population Acta Psychiatrica Scandinavica. ,vol. 113, pp. 54- 58 ,(2006) , 10.1111/J.1600-0447.2005.00648.X
Masanari Itokawa, Makoto Arai, Shuhei Kato, Yoko Ogata, Aizo Furukawa, Seiichi Haga, Hiroshi Ujike, Ichiro Sora, Kazuhiko Ikeda, Takeo Yoshikawa, Association between a novel polymorphism in the promoter region of the neuropeptide Y gene and schizophrenia in humans. Neuroscience Letters. ,vol. 347, pp. 202- 204 ,(2003) , 10.1016/S0304-3940(03)00718-3
Zhifeng Zhou, Guanshan Zhu, Ahmad R. Hariri, Mary-Anne Enoch, David Scott, Rajita Sinha, Matti Virkkunen, Deborah C. Mash, Robert H. Lipsky, Xian-Zhang Hu, Colin A. Hodgkinson, Ke Xu, Beata Buzas, Qiaoping Yuan, Pei-Hong Shen, Robert E. Ferrell, Stephen B. Manuck, Sarah M. Brown, Richard L. Hauger, Christian S. Stohler, Jon-Kar Zubieta, David Goldman, Genetic variation in human NPY expression affects stress response and emotion Nature. ,vol. 452, pp. 997- 1001 ,(2008) , 10.1038/NATURE06858
Rose-Marie Karlsson, Andrew Holmes, Markus Heilig, Jacqueline N. Crawley, Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacology, Biochemistry and Behavior. ,vol. 80, pp. 427- 436 ,(2005) , 10.1016/J.PBB.2004.12.009
Katharina Domschke, Christa Hohoff, Christian Jacob, Wolfgang Maier, Jürgen Fritze, Borwin Bandelow, Petra Krakowitzky, Florian Kästner, Matthias Rothermundt, Volker Arolt, Jürgen Deckert, Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants. American Journal of Medical Genetics. ,vol. 147, pp. 510- 516 ,(2008) , 10.1002/AJMG.B.30629